PCMP-E27 Antibody

What is PCPE-1 and why is it significant in extracellular matrix research?

PCPE-1 (Procollagen C-endopeptidase enhancer-1) is a secreted extracellular matrix glycoprotein composed of two CUB domains and one NTR domain. Its significance lies in its ability to stimulate enzymatic cleavage of procollagens I-III by the BMP-1/tolloid family of metalloproteases (also known as procollagen C-proteinases). This enhancement activity is specific to procollagens, as PCPE-1 shows no effect on BMP-1/tolloid cleavage of other substrates. PCPE-1 is primarily expressed in interstitial connective tissues including tendons, calvaria, and skin, making it an important marker for studying collagen processing and extracellular matrix organization .

How does PCPE-1 function in collagen processing?

PCPE-1 functions by binding to procollagen substrates and inducing conformational changes that make them more susceptible to cleavage by BMP-1/tolloid proteinases. The current understanding suggests two potential mechanisms: (1) PCPE-1 directly binds to procollagens and alters their conformation to facilitate enzymatic access, and (2) PCPE-1 may also interact with full-length BMP-1/tolloid proteinases, potentially forming a functional complex. The enhancer activity of PCPE-1 is highly specific to procollagens, as it does not affect BMP-1/tolloid processing of other extracellular substrates .

What are the structural domains of PCPE-1 and how do they relate to function?

PCPE-1 contains two CUB domains and one NTR domain. The CUB domains (complement protein subcomponents C1r/C1s, Uegf, and Bone morphogenetic protein-1) are approximately 110-amino-acid modules found in many developmentally regulated proteins. In PCPE-1, these domains are primarily responsible for binding to procollagen substrates. The NTR (netrin-like) domain at the C-terminus shares homology with tissue inhibitors of metalloproteases (TIMPs) but does not appear to have inhibitory activity against matrix metalloproteases. Instead, this domain may play a role in stabilizing protein-protein interactions or regulating PCPE-1 activity in specific tissue contexts .

What are the primary applications for PCPE-1 antibodies in research?

PCPE-1 antibodies are valuable tools for multiple research applications in extracellular matrix biology. The primary applications include:

• Western blotting for detection and quantification of PCPE-1 expression levels in cell and tissue lysates

• Immunohistochemistry/immunofluorescence for localization of PCPE-1 in tissue sections

• Co-immunoprecipitation experiments to study PCPE-1 interactions with procollagens and BMP-1/tolloid proteases

• ELISA-based quantification of secreted PCPE-1 in culture media or biological fluids

• Functional studies examining the role of PCPE-1 in collagen processing and fibrosis development

Research cited in the product literature indicates applications in studying liver fibrosis and corneal keratocyte myofibroblast transformation, demonstrating the antibody's utility in diverse pathophysiological contexts .

What are the optimal dilutions for using PCPE-1 antibody in different experimental protocols?

The optimal dilution for PCPE-1 antibody varies depending on the specific application and experimental conditions. According to the product information, dilutions should be determined empirically by each laboratory for their specific application. For Western blotting, starting dilutions typically range from 1:500 to 1:2000 based on antibody concentration and the abundance of the target protein in the sample. For immunohistochemistry, initial dilutions of 1:100 to 1:500 are commonly used. Optimization through titration experiments is strongly recommended to achieve the best signal-to-noise ratio. General protocols for various applications are available in the Technical Information section of the manufacturer's website .

How can I validate the specificity of PCPE-1 antibody in my experimental system?

Validating antibody specificity is critical for ensuring reliable research results. For PCPE-1 antibody, consider these validation strategies:

• Positive and negative control samples: Use tissues known to express PCPE-1 (tendons, calvaria, skin) as positive controls and tissues with minimal expression as negative controls

• Western blotting pattern analysis: Confirm detection of a band at the expected molecular weight (approximately 50-55 kDa for human PCPE-1)

• Genetic approaches: Compare antibody reactivity in wild-type versus PCPE-1 knockout or knockdown systems

• Peptide competition assays: Pre-incubate the antibody with excess purified antigen to demonstrate signal elimination

• Orthogonal methods: Confirm protein expression using alternative techniques like mass spectrometry or RNA expression analysis

These validation steps are essential to ensure that experimental observations truly reflect PCPE-1 biology rather than non-specific antibody binding .

What are the optimal storage conditions for maintaining PCPE-1 antibody activity?

Proper storage is crucial for maintaining antibody activity and specificity. For PCPE-1 antibody, the following storage guidelines should be followed:

• Long-term storage (up to 12 months from receipt): -20°C to -70°C in the original container

• Medium-term storage (up to 1 month): 2°C to 8°C under sterile conditions after reconstitution

• Extended storage after reconstitution (up to 6 months): -20°C to -70°C under sterile conditions

It is important to use a manual defrost freezer and avoid repeated freeze-thaw cycles, as these can significantly degrade antibody quality. Aliquoting the reconstituted antibody into single-use volumes before freezing can minimize freeze-thaw cycles and preserve antibody function .

What is the recommended reconstitution procedure for lyophilized PCPE-1 antibody?

The reconstitution procedure should follow manufacturer guidelines precisely. While specific details for this particular antibody aren't provided in the search results, standard reconstitution procedures typically involve:

• Allow the lyophilized antibody to reach room temperature before opening

• Reconstitute with sterile water, PBS, or the manufacturer's recommended buffer

• Gently mix by rotating or inverting the vial (avoid vigorous shaking or vortexing)

• Allow the solution to stand for 5-10 minutes at room temperature

• If not using immediately, prepare aliquots to avoid repeated freeze-thaw cycles

A reconstitution calculator may be available on the manufacturer's website to determine the appropriate volume of reconstitution buffer based on the desired final concentration .

How can I address non-specific binding when using PCPE-1 antibody in Western blotting?

Non-specific binding is a common challenge when using antibodies in Western blotting. For PCPE-1 antibody, consider these approaches:

• Optimization of blocking conditions: Test different blocking agents (5% non-fat milk, 3-5% BSA, commercial blocking buffers) to reduce background

• Increase antibody specificity: Use higher dilutions of primary antibody or implement more stringent washing steps

• Buffer optimization: Adjust salt concentration or add low concentrations of detergents (0.05-0.1% Tween-20) to reduce non-specific interactions

• Sample preparation: Ensure complete protein denaturation and use fresh samples to prevent degradation products

• Consider additional purification: If persistent non-specific binding occurs, pre-absorb the antibody against tissues lacking PCPE-1 expression

The antibody is considered to pass Western blotting specifications if it produces a band of the expected molecular weight for PCPE-1 with minimal off-target bands (fewer than 3) at lower intensity .

What experimental approaches can confirm that PCPE-1 antibody recognizes the native protein conformation?

Confirming recognition of native PCPE-1 requires techniques beyond Western blotting, which primarily detects denatured proteins. Consider these approaches:

• Immunoprecipitation (IP): Successfully pulling down PCPE-1 from non-denatured cell lysates indicates recognition of the native conformation

• Enzyme-linked immunosorbent assay (ELISA): Direct or sandwich ELISA using non-denatured samples

• Flow cytometry: For cell-surface or intracellular detection with appropriate permeabilization

• Immunofluorescence microscopy: Observing expected subcellular localization patterns (primarily secretory pathway and extracellular matrix for PCPE-1)

• Functional assays: Testing whether the antibody can inhibit PCPE-1 enhancement of procollagen processing in vitro

These complementary approaches provide stronger evidence that the antibody recognizes physiologically relevant PCPE-1 conformations .

How can PCPE-1 antibody be used to study fibrotic disease mechanisms?

PCPE-1 antibody offers valuable insights into fibrotic disease mechanisms through several experimental approaches:

• Expression analysis: Quantify PCPE-1 levels in fibrotic versus normal tissues to establish correlation with disease progression

• Cellular localization: Identify cell types overexpressing PCPE-1 in fibrotic tissues using immunohistochemistry or immunofluorescence

• Mechanistic studies: Investigate how PCPE-1 expression changes in response to profibrotic stimuli

• Intervention assessment: Monitor PCPE-1 levels as a biomarker for antifibrotic therapy efficacy

• Functional blockade: Use blocking antibodies against PCPE-1 to assess potential therapeutic effects

Published research has specifically examined PCPE-1 deficiency in mouse models of liver fibrosis and non-alcoholic steatohepatitis (NASH), providing evidence for PCPE-1's role in fibrotic processes. This suggests PCPE-1 antibodies are valuable tools for investigating fibrotic disease mechanisms .

What experimental considerations are important when studying PCPE-1 in the context of collagen processing?

Studying PCPE-1's role in collagen processing requires careful experimental design:

• Selection of appropriate cell models: Use cells that produce significant amounts of fibrillar collagens and PCPE-1 (fibroblasts, osteoblasts, or hepatic stellate cells)

• Collagen substrate specificity: Remember that PCPE-1 enhances processing of fibrillar procollagens (types I-III) but not other BMP-1/tolloid substrates

• Co-factor requirements: Account for potential cofactors that may influence PCPE-1 activity in different tissue contexts

• Temporal considerations: Monitor both early (procollagen processing) and late (fibril formation) stages of collagen maturation

• Combined protein and activity assays: Measure both PCPE-1 protein levels and functional enhancement of procollagen C-proteinase activity

These considerations help ensure that experiments accurately capture the specific role of PCPE-1 in collagen maturation rather than general effects on extracellular matrix organization .

How can PCPE-1 antibody be used in multiplex immunoassays with other extracellular matrix markers?

Multiplex immunoassays that simultaneously detect multiple extracellular matrix proteins, including PCPE-1, provide comprehensive insights into matrix remodeling. Key considerations include:

• Antibody compatibility: Ensure primary antibodies are raised in different host species or use directly conjugated antibodies to avoid cross-reactivity

• Signal separation: Use fluorophores with distinct excitation/emission spectra for immunofluorescence or different enzyme systems for chromogenic detection

• Optimization of fixation and antigen retrieval: Different ECM proteins may require different conditions for optimal detection

• Sequential staining protocols: Consider sequential rather than simultaneous staining if antibodies have incompatible buffer requirements

• Controls for signal specificity: Include single-stain controls and blocking controls to ensure signal specificity

Combining PCPE-1 detection with markers for collagens, processing enzymes (BMP-1/tolloid proteinases), and other ECM components provides comprehensive visualization of collagen maturation networks in normal and pathological tissues .

What is the significance of PCPE-1 in hypoxia-induced corneal keratocyte transformation?

Research using PCPE-1 antibody has revealed important insights into corneal biology. Studies show that hypoxic conditions reduce TGFβ1-induced corneal keratocyte myofibroblast transformation. PCPE-1 antibody was employed to investigate the protein's role in this process, contributing to our understanding of corneal wound healing and fibrosis. The ability to detect changes in PCPE-1 expression under different oxygen tensions provides valuable information about extracellular matrix remodeling during corneal responses to injury and stress. This research demonstrates how PCPE-1 antibody can be used to investigate tissue-specific regulation of collagen processing under pathophysiological conditions .

What emerging research questions about PCPE-1 can be addressed using the antibody?

Several promising research directions can be explored using PCPE-1 antibody:

• Tissue-specific regulation: How does PCPE-1 expression and function vary across different tissues and developmental stages?

• Pathological roles: Beyond liver fibrosis, what roles does PCPE-1 play in other fibrotic or ECM-related pathologies?

• Intracellular versus extracellular functions: Does PCPE-1 have additional functions before secretion?

• Post-translational modifications: How do glycosylation or other modifications affect PCPE-1 activity?

• Therapeutic targeting: Can modulation of PCPE-1 activity serve as a therapeutic approach for fibrotic diseases?

The antibody enables detection and quantification of PCPE-1 in diverse experimental systems, facilitating investigation of these important questions in extracellular matrix biology and pathology .